NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
VYNE Therapeutics Inc (NASDAQ: VYNE)
VYNE Technical Analysis
5
As on 18th May 2022 VYNE Share Price closed @ 0.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.66 & Strong Sell for SHORT-TERM with Stoploss of 7.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VYNE Share Price
Open | 0.38 | Change | Price | % |
High | 0.42 | 1 Day | -0.01 | -2.44 |
Low | 0.38 | 1 Week | 0.01 | 2.56 |
Close | 0.40 | 1 Month | -0.31 | -43.66 |
Volume | 365797 | 1 Year | -6.40 | -94.12 |
52 Week High 12.68 | 52 Week Low 0.37 |
NASDAQ USA Most Active Stocks
AMD | 96.28 | -6.04% |
AAPL | 140.82 | -5.64% |
BRQS | 0.19 | 11.76% |
SNDL | 0.41 | -6.82% |
GNUS | 0.78 | 13.04% |
AGRI | 2.92 | 8.96% |
BBIG | 3.05 | 6.64% |
ENDP | 0.62 | -46.55% |
NVDA | 169.38 | -6.82% |
SOFI | 7.23 | 2.55% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
VYNE Daily Charts |
VYNE Intraday Charts |
Whats New @ Bazaartrend |
VYNE Free Analysis |
|
VYNE Important Levels Intraday
RESISTANCE | 0.48 |
RESISTANCE | 0.45 |
RESISTANCE | 0.44 |
RESISTANCE | 0.42 |
SUPPORT | 0.38 |
SUPPORT | 0.36 |
SUPPORT | 0.35 |
SUPPORT | 0.32 |
VYNE Target for Month May
4th UP TARGET | 13.81 |
3rd UP TARGET | 9.51 |
2nd UP TARGET | 6.85 |
1st UP TARGET | 4.19 |
1st DOWN TARGET | -3.39 |
2nd DOWN TARGET | -6.05 |
3rd DOWN TARGET | -8.71 |
4th DOWN TARGET | -13.01 |
VYNE Weekly Target
4th UP TARGET | 1.71 |
3rd UP TARGET | 1.29 |
2nd UP TARGET | 1.03 |
1st UP TARGET | 0.77 |
1st DOWN TARGET | 0.03 |
2nd DOWN TARGET | -0.23 |
3rd DOWN TARGET | -0.49 |
4th DOWN TARGET | -0.91 |
VYNE Target for Year 2022
4th UP TARGET | 25.18 |
3rd UP TARGET | 17.23 |
2nd UP TARGET | 12.32 |
1st UP TARGET | 7.41 |
1st DOWN TARGET | -6.61 |
2nd DOWN TARGET | -11.52 |
3rd DOWN TARGET | -16.43 |
4th DOWN TARGET | -24.38 |
VYNE Therapeutics Inc ( NASDAQ USA Symbol : VYNE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VYNE Other Details
Segment | EQ | |
Market Capital | 65935104.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
VYNE Address
![]() |
VYNE Latest News
VYNE Business Profile
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey. Address: 520 U.S. Highway 22, Bridgewater, NJ, United States, 08807
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service